The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation.
canagliflozin 對於 imiquimod 誘導的小鼠類銀屑病炎症模型的緩解效果。
Naunyn Schmiedebergs Arch Pharmacol 2024-09-10
Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway.
Canagliflozin透過FGF21-ERK1/2途徑阻止NLRP3介導的焦亡作用,改善NAFLD的發展。
Hepatol Commun 2024-02-12
Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.
Empagliflozin透過抑制一氧化氮合成和髓過氧化物酶活性,在結腸炎的體外和體內模型中減輕腸道炎症。
Inflammopharmacology 2024-03-05
[Effects of canagliflozin on amino acid metabolism in atherosclerotic mice].
「Canagliflozin對動脈粥樣硬化小鼠的氨基酸代謝影響」
Zhonghua Xin Xue Guan Bing Za Zhi 2024-01-16